• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

精神分裂症中多巴胺周转减少及失调的证据。

Evidence for reduced and dysregulated turnover of dopamine in schizophrenia.

作者信息

Heritch A J

机构信息

Dept. of Psychiatry, Medical College of Wisconsin, Milwaukee 53226.

出版信息

Schizophr Bull. 1990;16(4):605-15. doi: 10.1093/schbul/16.4.605.

DOI:10.1093/schbul/16.4.605
PMID:2077638
Abstract

The dopamine (DA) hypothesis of schizophrenia proposes that schizophrenia is related to dopaminergic hyperactivity. To examine this hypothesis, this article reviews studies that have measured levels of DA and its metabolites in schizophrenic patients. From these studies, the following conclusions about schizophrenia emerge: (1) levels of DA and its metabolites can be highly variable; (2) DA turnover appears to be reduced in a subgroup of schizophrenic patients characterized as more chronic and treatment refractory, compared with normal controls; (3) DA turnover has been correlated positively with acute symptomatology and negatively with signs of chronic illness; and (4) central DA levels appear to be elevated. These conclusions support the author's hypothesis that DA turnover may be both reduced and dysregulated in schizophrenia. It is speculated that reduced turnover is primarily due to a deficiency in DA release and that dysregulation may result from the disruption of feedback mechanisms. Acute psychosis may be associated with a relative increase in the release of DA impinging on supersensitive postsynaptic receptors made so by chronic synaptic depletion of the transmitter.

摘要

精神分裂症的多巴胺(DA)假说提出,精神分裂症与多巴胺能亢进有关。为检验这一假说,本文回顾了测量精神分裂症患者体内DA及其代谢物水平的研究。从这些研究中,得出了以下关于精神分裂症的结论:(1)DA及其代谢物的水平可能高度可变;(2)与正常对照组相比,在一组以病程较长且治疗难治为特征的精神分裂症患者中,DA周转率似乎降低;(3)DA周转率与急性症状呈正相关,与慢性病体征呈负相关;(4)中枢DA水平似乎升高。这些结论支持了作者的假说,即精神分裂症中DA周转率可能既降低又失调。据推测,周转率降低主要是由于DA释放不足,而失调可能是由反馈机制破坏所致。急性精神病可能与作用于超敏突触后受体的DA释放相对增加有关,这种超敏是由递质的慢性突触耗竭造成的。

相似文献

1
Evidence for reduced and dysregulated turnover of dopamine in schizophrenia.精神分裂症中多巴胺周转减少及失调的证据。
Schizophr Bull. 1990;16(4):605-15. doi: 10.1093/schbul/16.4.605.
2
The biochemical basis of relapse and drug response in schizophrenia: review and hypothesis.精神分裂症复发与药物反应的生化基础:综述与假说
Psychol Med. 1991 Nov;21(4):881-95. doi: 10.1017/s0033291700029871.
3
Apomorphine and the dopamine hypothesis of schizophrenia: a dilemma?阿扑吗啡与精神分裂症的多巴胺假说:一个困境?
J Psychiatry Neurosci. 2001 May;26(3):203-20.
4
The role of dopamine for the pathophysiology of schizophrenia.多巴胺在精神分裂症病理生理学中的作用。
Int Rev Psychiatry. 2007 Aug;19(4):337-45. doi: 10.1080/09540260701502468.
5
Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia.精神分裂症阳性和阴性症状的神经化学及神经机制
Mod Probl Pharmacopsychiatry. 1990;24:124-51. doi: 10.1159/000418015.
6
Monoamines and schizophrenia.单胺与精神分裂症
Acta Psychiatr Scand Suppl. 1990;358:7-13. doi: 10.1111/j.1600-0447.1990.tb05279.x.
7
Dopamine and norepinephrine activity in schizophrenia. An integrative perspective.
Schizophr Res. 1991 Mar-Apr;4(2):173-91. doi: 10.1016/0920-9964(91)90032-m.
8
A theoretical and neurophysiological consideration on the pathogenesis of positive symptoms of schizophrenia: implications of dopaminergic function in the emotional circuit.
Jpn J Psychiatry Neurol. 1994 Mar;48(1):99-110. doi: 10.1111/j.1440-1819.1994.tb03003.x.
9
A D2 dopamine receptor agonist disrupts sensorimotor gating in rats. Implications for dopaminergic abnormalities in schizophrenia.一种D2多巴胺受体激动剂会破坏大鼠的感觉运动门控。这对精神分裂症中多巴胺能异常的意义。
Neuropsychopharmacology. 1990 Jun;3(3):211-8.
10
Is there a right hemi-hyper-dopaminergic psychosis?
Schizophr Res. 1989 Jul-Oct;2(4-5):317-24. doi: 10.1016/0920-9964(89)90022-4.

引用本文的文献

1
Prefrontal dysfunction and a monkey model of schizophrenia.前额叶功能障碍与精神分裂症的猴子模型
Neurosci Bull. 2015 Apr;31(2):235-41. doi: 10.1007/s12264-014-1506-4. Epub 2015 Mar 31.
2
The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.新型神经降压素类似物 NT69L 可阻断苯环利定(PCP)引起的活动增加以及 PCP 引起的内侧前额叶皮层中单胺和氨基酸水平的增加。
Brain Res. 2010 Jan 22;1311:28-36. doi: 10.1016/j.brainres.2009.11.048. Epub 2009 Nov 27.
3
Extracellular dopamine and norepinephrine in the developing rat prefrontal cortex: transient effects of early partial loss of dopamine.
发育中大鼠前额叶皮质的细胞外多巴胺和去甲肾上腺素:多巴胺早期部分缺失的短暂影响
Brain Res Bull. 2009 Apr 29;79(2):104-110. doi: 10.1016/j.brainresbull.2009.01.012.
4
Pharmacological management of schizophrenia in older patients.
Drugs Aging. 1994 Oct;5(4):254-62. doi: 10.2165/00002512-199405040-00003.